Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.

Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nightingale P, Koutedakis Y, Kitas GD.

Arthritis Res Ther. 2012 Jul 5;14(4):R160. doi: 10.1186/ar3900.

2.

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.

Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, Kardassis D, Boumpas DT, Sidiropoulos PI.

Arthritis Res Ther. 2012 Jun 12;14(3):R141. doi: 10.1186/ar3874.

3.

Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.

Rosenvinge A, Krogh-Madsen R, Baslund B, Pedersen BK.

Scand J Rheumatol. 2007 Mar-Apr;36(2):91-6.

PMID:
17476613
4.

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.

Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA.

Ann Rheum Dis. 2005 May;64(5):765-6. Epub 2004 Sep 30.

5.

Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.

Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Avalos I, Sokka T, Raggi P, Pincus T, Stein CM.

Arthritis Rheum. 2008 Jul;58(7):2105-12. doi: 10.1002/art.23600.

6.

Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.

Ormseth MJ, Oeser AM, Cunningham A, Bian A, Shintani A, Solus J, Tanner S, Stein CM.

Arthritis Res Ther. 2013;15(5):R110.

7.

Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Burska AN, Sakthiswary R, Sattar N.

PLoS One. 2015 Jun 25;10(6):e0128889. doi: 10.1371/journal.pone.0128889. eCollection 2015. Review.

8.

Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.

Bradham WS, Ormseth MJ, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM.

Inflammation. 2014 Jun;37(3):801-8. doi: 10.1007/s10753-013-9799-4.

9.

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.

Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Okuno Y, Nishizawa Y.

Diabetes Care. 2003 Aug;26(8):2426-32.

PMID:
12882874
10.

Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.

Sandoo A, Dimitroulas T, Toms TE, Hodson J, Veldhuijzen van Zanten JJ, Smith JP, Kitas GD.

Clin Biochem. 2012 Nov;45(16-17):1399-403. doi: 10.1016/j.clinbiochem.2012.07.092. Epub 2012 Jul 20.

PMID:
22820438
11.

Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?

Cuchacovich R, Espinoza LR.

Clin Rheumatol. 2009 Oct;28(10):1217-20. doi: 10.1007/s10067-009-1208-x. Epub 2009 Jun 11.

PMID:
19517156
12.

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine.

Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, Favalli EG, Erre GL, Gorla R, Galeazzi M, Foti R, Cantini F, Salvarani C, Olivieri I, Lapadula G, Ferraccioli G; Gruppo Italiano di Studio sulle Early Arthritis (GISEA).

Arthritis Care Res (Hoboken). 2013 Jan;65(1):94-100. doi: 10.1002/acr.21768.

13.

Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.

Antohe JL, Bili A, Sartorius JA, Kirchner HL, Morris SJ, Dancea S, Wasko MC.

Arthritis Care Res (Hoboken). 2012 Feb;64(2):215-21. doi: 10.1002/acr.20657.

14.

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):83-6.

PMID:
16539824
15.

CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.

Rość D, Adamczyk P, Boinska J, Szafkowski R, Ponikowska I, Stankowska K, Góralczyk B, Ruszkowska-Ciastek B.

J Zhejiang Univ Sci B. 2015 May;16(5):404-11. doi: 10.1631/jzus.B1400219.

16.

Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.

Radovits BJ, Kievit W, Laan RF.

Drugs Aging. 2009;26(8):647-64. doi: 10.2165/11316460-000000000-00000. Review.

PMID:
19685931
17.

Increased prevalence of allergic sensitisation in rheumatoid arthritis patients treated with anti-TNFalpha.

Machado P, Santos A, Pereira C, Loureiro C, Silva J, Chieira C, Malcata A.

Joint Bone Spine. 2009 Oct;76(5):508-13. doi: 10.1016/j.jbspin.2009.01.007. Epub 2009 May 21.

PMID:
19467899
18.

The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis.

Dessein PH, Joffe BI, Stanwix A, Botha AS, Moomal Z.

J Rheumatol. 2002 Mar;29(3):462-6.

PMID:
11908557
19.

Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.

Gonzalez-Gay MA, Vazquez-Rodriguez TR, Garcia-Unzueta MT, Berja A, Miranda-Filloy JA, de Matias JM, Gonzalez-Juanatey C, Llorca J.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):56-62.

PMID:
20346239
20.

Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.

Savioli C, Ribeiro AC, Fabri GM, Calich AL, Carvalho J, Silva CA, Viana VS, Bonfá E, Siqueira JT.

J Clin Rheumatol. 2012 Jun;18(4):180-4. doi: 10.1097/RHU.0b013e31825828be.

PMID:
22647860
Items per page

Supplemental Content

Write to the Help Desk